Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,534
Total Claims
$1.2M
Drug Cost
559
Beneficiaries
$2,169
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 44,021 Emergency Medicine providers
-90%
Opioid rate vs peers
0.9% vs 9.4% avg
+760%
Brand preference vs peers
12.8% vs 1.5% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.9%
Opioid Rate
89
Opioid Claims
$633
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,209 claims · $959K
Generic: 8,269 claims · $251K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 142 | $188K |
| Apixaban | 53 | $58K |
| Empagliflozin | 52 | $52K |
| Dapagliflozin Propanediol | 37 | $48K |
| Dapaglifloz Propaned/Metformin | 46 | $44K |
| Dulaglutide | 32 | $41K |
| Semaglutide | 22 | $40K |
| Rivaroxaban | 36 | $35K |
| Linaclotide | 29 | $29K |
| Tirzepatide | 20 | $29K |
| Fluticasone/Umeclidin/Vilanter | 12 | $22K |
| Sitagliptin Phosphate | 12 | $20K |
| Insulin Glargine,hum.Rec.Anlog | 33 | $19K |
| Insulin Lispro | 26 | $15K |
| Fluticasone/Vilanterol | 17 | $14K |
Prescribing Profile
Patient Profile
74
Avg Age
61%
Female
1.35
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About